Welcome to Psynomics
Psynomics is the first and only company in the world to offer DNA-based diagnostic and therapeutic tests to help millions of people suffering from mental illness. These are diagnostic tests whose results must interpreted by a psychiatrist.

Our first two products:
Psynome™ – tests for two mutations of the GRK3 gene that are associated with bipolar disorder.

Psynome2™ –tests for gene mutations in the Promoter L allele gene that predicts patient response to serotonin-based drugs, the most commonly prescribed drug therapies in psychiatry today. These tests are useful to your doctor in making a timely and accurate diagnosis of your condition and prescribing the right medication.  The tests can be ordered individually or combined.